Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeorgia Capital Regulatory News (CGEO)

Share Price Information for Georgia Capital (CGEO)

Share Price is delayed by 15 minutes
Get Live Data
3,950.00    65.00 (1.67%)
Bid:
3,925.00
Ask:
3,940.00
Spread: 15.00 (0.382%)
Market Cap: £1.22b
CGEO Live PriceLast checked at - London Stock Exchange

Intraday Georgia Capital Share Chart

Tender Offer Results

25 Oct 2022 11:05

RNS Number : 0425E
Georgia Capital PLC
25 October 2022
Β 

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014 (THE "MARKET ABUSE REGULATION")

NOT FOR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (THE "UNITED STATES") OR TO ANY U.S. PERSON (AS DEFINED BELOW) OR TO ANY PERSON LOCATED OR RESIDENT IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT

25 October 2022

JSC GEORGIA CAPITAL ANNOUNCES RESULTS OF TENDER OFFER TO PURCHASE NOTES FOR CASH

JSC Georgia Capital (the "Issuer") announces today the results of the tender offer that the Issuer commenced on 14 October 2022, for its outstanding U.S.$365,000,000 6.125% Notes due 2024 (the "Notes"), for cash (the "Tender Offer"). The terms of the Tender Offer are described in a tender offer memorandum dated 14 October 2022 (the "Tender Offer Memorandum").

Capitalised terms used in this announcement but not otherwise defined have the meanings given to them in the Tender Offer Memorandum.

Results of the Tender Offer

The Tender Offer expired at 4:00 p.m. (London time) on 24 October 2022. The following table sets forth the results of the Tender Offer, including the Final Tender Cap and the Purchase Price per U.S.$1,000 in principal amount of Notes accepted for purchase in the Tender Offer, as determined in accordance with the Modified Dutch Auction Procedure and subject to the terms as set out in the Tender Offer Memorandum.

Β 

Description of the Notes

ISIN / Common Code (Reg S)

Β 

Minimum Denomination

Β 

Minimum Purchase Price

Β 

Maximum Purchase Price

Purchase Price

Aggregate Principal Amount of Notes accepted for purchase (Final Tender Cap)

U.S.$365,000,000 6.125% notes held on the Regulation S Global Certificate bearing ISIN XS1778929478

ISIN: XS1778929478 / 177892947

U.S.$200,000 and integral multiples of U.S.$1,000 thereafter

U.S.$880 per U.S.$1,000 in principal amount of the Notes

U.S.$950 per U.S.$1,000 in principal amount of the Notes

U.S.$880 per U.S.$1,000 in principal amount of the Notes

U.S.$29,170,000

The Issuer intends to cancel US$29,170,000 in aggregate principal amount of the Notes it accepts for purchase pursuant to the Tender Offer and US$35,830,000 million in aggregate principal amount owned by the Issuer. Following settlement of the Tender Offer and the cancellation of US$29,170,000 in aggregate principal amount of the Notes accepted by the Issuer for purchase pursuant to the Tender Offer and US$35,830,000 in aggregate principal amount of the Notes owned by the Issuer, U.S.$300,000,000 in aggregate principal amount of the Notes will remain outstanding, of which US$34,552,000 will be owned by the Issuer and its affiliates.

Payment of the Purchase Price and the Accrued Interest Amount

The Issuer will also pay an Accrued Interest Payment in respect of any Notes accepted for purchase pursuant to the Tender Offer, as further described in the Tender Offer Memorandum. The Purchase Price and the Accrued Interest Amount for the Notes accepted for purchase in the Tender Offer will each be paid on the Payment Date, which is expected to be 26 October 2022.

Further Information

Questions and requests for assistance in connection with the Tender Offer may be directed to:

The Dealer Manager

J.P. Morgan Securities plc

25 Bank Street

Canary Wharf

London E14 5JP

United Kingdom

Β 

Email: em_europe_lm@jpmorgan.com

Attention: Liability Management

Tel: +44 20 7134 2468

The Tender and Information Agent

Kroll Issuer Services Limited

The Shard32 London Bridge StreetLondon SE1 9SG

United Kingdom

Β 

Attention: Jacek Kusion / Illia Vyshenskyi

Tel: +44 20 7704 0880

Email: gcap@is.kroll.com

Website: https://deals.is.kroll.com/gcap

DISCLAIMER

This announcement must be read in conjunction with the Tender Offer Memorandum. No offer or invitation to acquire or exchange any notes is being made pursuant to this announcement. This announcement and the Tender Offer Memorandum contain important information, which must be read carefully. If any Noteholder is in any doubt as to the contents of this announcement or the Tender Offer Memorandum or the action it should take, it is recommended to seek its own legal, tax and financial advice, including as to any tax consequences, immediately from its stockbroker, bank manager, solicitor, accountant or other independent financial adviser. None of the Issuer, the Dealer Manager, the Tender and Information Agent, or any person who controls, or is a director, officer, employee or agent of such persons, or any affiliate of such persons, makes any representation or recommendation whatsoever regarding this announcement, the Tender Offer Memorandum or the Tender Offer.

This announcement is released by JSC Georgia Capital and contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation, encompassing information relating to the Tender Offer described above. For the purposes of the Market Abuse Regulation, this announcement is made by Giorgi Alpaidze, the Chief Financial Officer of JSC Georgia Capital.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RTEEAEESAEEAFFA
Date   Source Headline
29th Jun 202612:00 pmRNSTransaction in Own Shares
29th Jun 20267:00 amRNSBond redemption and extension of buyback programme
22nd Jun 20262:03 pmRNSTransaction in Own Shares
17th Jun 20262:54 pmRNSDirector/PDMR Shareholding
17th Jun 202611:45 amRNSHolding(s) in Company
15th Jun 202611:41 amRNSTransaction in Own Shares
11th Jun 20265:07 pmRNSDirector/PDMR Shareholding
10th Jun 202612:30 pmRNSS&P upgrades credit rating of Georgia Capital
10th Jun 202611:06 amRNSReplacement - Total Voting Rights
9th Jun 202612:15 pmRNSResult of AGM
8th Jun 20263:25 pmRNSTransaction in Own Shares
5th Jun 20262:40 pmRNSDisposal of the housing development business
1st Jun 20264:04 pmRNSTotal Voting Rights
1st Jun 20262:42 pmRNSTransaction in Own Shares
26th May 202612:08 pmRNSTransaction in Own Shares
21st May 20265:16 pmRNSReplacement - Director/PDMR Shareholding
20th May 20265:42 pmRNSDirector/PDMR Shareholding
18th May 20262:32 pmRNSTransaction in Own Shares
11th May 20264:00 pmRNSNotice of AGM
11th May 20269:58 amRNSTransaction in Own Shares
5th May 20269:59 amRNSTransaction in Own Shares
1st May 202610:14 amRNSTotal Voting Rights
28th Apr 20267:00 amRNS1st Quarter Results
27th Apr 20269:57 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSAnnual Financial Report
21st Apr 202611:58 amRNSNotice of Results
20th Apr 202611:34 amRNSTransaction in Own Shares
13th Apr 20269:39 amRNSTransaction in Own Shares
7th Apr 20263:26 pmRNSDirector/PDMR Shareholding
7th Apr 202610:03 amRNSTransaction in Own Shares
1st Apr 202612:02 pmRNSTotal Voting Rights
30th Mar 20269:41 amRNSTransaction in Own Shares
26th Mar 20261:54 pmRNSCancellation of Treasury Shares
20th Mar 20264:57 pmRNSTransaction in Own Shares
19th Mar 20265:01 pmRNSTransaction in Own Shares
18th Mar 20265:06 pmRNSTransaction in Own Shares
18th Mar 20263:27 pmRNSCancellation of Treasury Shares
17th Mar 20265:21 pmRNSTransaction in Own Shares
16th Mar 20265:00 pmRNSTransaction in Own Shares
13th Mar 20264:57 pmRNSTransaction in Own Shares
12th Mar 20265:06 pmRNSTransaction in Own Shares
12th Mar 202611:02 amRNSHolding(s) in Company
12th Mar 202610:19 amRNSDirector/PDMR Shareholding
11th Mar 20265:08 pmRNSTransaction in Own Shares
11th Mar 20265:08 pmRNSTransaction in Own Shares
11th Mar 202611:31 amRNSCancellation of Treasury Shares
11th Mar 202611:31 amRNSCancellation of Treasury Shares
10th Mar 20265:04 pmRNSTransaction in Own Shares
9th Mar 20265:04 pmRNSTransaction in Own Shares
6th Mar 20265:08 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.